News
Evidence-based recommendations on idebenone (Raxone) for treating visual impairment in Leber’s hereditary optic neuropathy in people 12 years and over. Last reviewed: 28 August 2025 Next review: This ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback